22nd Century Group’s (XXII) “Sell (E)” Rating Reaffirmed at Weiss Ratings

Weiss Ratings reaffirmed their sell (e) rating on shares of 22nd Century Group (NASDAQ:XXII) in a research report report published on Thursday,Weiss Ratings reports.

Separately, Wall Street Zen cut 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd.

22nd Century Group Price Performance

NASDAQ:XXII opened at $2.34 on Thursday. The business has a 50 day moving average of $6.34 and a 200 day moving average of $27.24. The company has a market capitalization of $1.19 million, a price-to-earnings ratio of 0.00 and a beta of 1.72. 22nd Century Group has a 1-year low of $2.18 and a 1-year high of $1,892.50.

22nd Century Group (NASDAQ:XXII) last announced its quarterly earnings results on Thursday, August 14th. The biotechnology company reported ($13.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($12.89). The company had revenue of $4.08 million during the quarter, compared to analysts’ expectations of $5.44 million. 22nd Century Group had a negative return on equity of 388.90% and a negative net margin of 80.22%.

Hedge Funds Weigh In On 22nd Century Group

A hedge fund recently raised its stake in 22nd Century Group stock. Anson Funds Management LP boosted its stake in 22nd Century Group, Inc (NASDAQ:XXII) by 255.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 176,094 shares of the biotechnology company’s stock after purchasing an additional 126,536 shares during the period. Anson Funds Management LP owned about 7.43% of 22nd Century Group worth $254,000 at the end of the most recent reporting period. 18.06% of the stock is owned by institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.